Jump to content

Regeneron likely to make coronavirus treatments available in few months


webfact

Recommended Posts

Regeneron likely to make coronavirus treatments available in few months

 

2020-02-06T140733Z_2_LYNXMPEG151B9_RTROPTP_4_CHINA-HEALTH-USA.JPG

The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS/Files

 

(Reuters) - Regeneron Pharmaceuticals Inc is ramping up efforts to develop a set of coronavirus treatments, which could be available for testing or use in some patients within a few months, the drugmaker said on Thursday.

 

The drugmaker on Tuesday expanded its arrangement with the U.S. Department of Health and Human Services to collaborate on developing a treatment, joining the race to develop a treatment for the virus that has killed more than 550 people.

 

Regeneron said the treatments could be made available through a "compassionate use" program that provides patients access to experimental drugs outside of a clinical trial when there are no viable alternatives.

 

"We're already scaling up one set of potential antibody treatments," Chief Scientific Officer George Yancopoulos said on a conference call with analysts.

 

Regeneron has said it is focusing on developing infection-fighting proteins known as monoclonal antibodies and use the same technology that was used to develop an experimental drug to treat Ebola in the Democratic Republic of Congo.

 

Shares of the company rose 4% to $387 in trading before the bell as it also reported a better-than-expected fourth-quarter profit.

 

(Reporting by Manas Mishra and Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty)

 

reuters_logo.jpg

-- © Copyright Reuters 2020-02-07
Link to comment
Share on other sites

50 minutes ago, fvw53 said:

To bring a new FDA drug on the market ....I learned ......it takes between 12 and 20 years ....what can happen in a  few months ?  Shares going up only ?

Exceptions are made. Clinical trials aren't needed, though there may be ethical questions, when there is a health care emergency, and approved treatments do not exist.

  • Like 1
Link to comment
Share on other sites

"Regeneron said the treatments could be made available through a "compassionate use" program that provides patients access to experimental drugs outside of a clinical trial when there are no viable alternatives."

 

Yes mate, of course. Nothing to do with testing a few drugs that wouldn't qualify for even a Phase 1 trial.

 

Just "Happy To Help".

 

:laugh:

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.










×
×
  • Create New...